Cumberland Partners Ltd
Source: SEC Form 13F · as of Mar 2026Cumberland Partners Ltd holds 13 biotech & pharma companies tracked by BioSniper, totaling $118.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
13
Total value held
$118.0M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 36,235 | $33.3M |
| AZNASTRAZENECA PLC | 145,746 | $28.7M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 65,237 | $17.7M |
| JNJJOHNSON & JOHNSON | 32,060 | $7.8M |
| ABBVAbbVie Inc. | 25,507 | $5.5M |
| PFEPFIZER INC | 191,855 | $5.4M |
| PMPhilip Morris International Inc | 31,580 | $5.2M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 9,376 | $4.2M |
| MCKMcKesson Corporation | 4,375 | $3.8M |
| RPRXRoyalty Pharma plc | 50,000 | $2.4M |
| IQVIQVIA Holdings Inc. | 10,005 | $1.7M |
| REGNREGENERON PHARMACEUTICALS, INC. | 1,500 | $1.2M |
| ZTSZoetis Inc. | 8,900 | $1.1M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.